Wong B, Tan H
Microb Genom. 2025; 11(1).
PMID: 39853209
PMC: 11893279.
DOI: 10.1099/mgen.0.001339.
Afrad M, Islam M, Begum Y, Saifullah M, Ahmmed F, Khan Z
Microbiol Spectr. 2024; :e0073924.
PMID: 39540737
PMC: 11619575.
DOI: 10.1128/spectrum.00739-24.
Qiu S, Liu K, Yang C, Xiang Y, Min K, Zhu K
Nat Commun. 2022; 13(1):7365.
PMID: 36450777
PMC: 9709761.
DOI: 10.1038/s41467-022-35136-1.
Gasperini G, Raso M, Schiavo F, Aruta M, Ravenscroft N, Bellich B
NPJ Vaccines. 2022; 7(1):69.
PMID: 35773292
PMC: 9243986.
DOI: 10.1038/s41541-022-00497-7.
Clarkson K, Porter C, Talaat K, Kapulu M, Chen W, Frenck Jr R
Curr Top Microbiol Immunol. 2022; 445:257-313.
PMID: 35616717
PMC: 7616482.
DOI: 10.1007/82_2021_248.
Update on and Nontyphoidal Salmonella Antimicrobial Drug Resistance: Implications on Empirical Treatment of Acute Infectious Diarrhea in Cambodia.
Poramathikul K, Wojnarski M, Sok S, Sokh V, Chiek S, Seng H
Antimicrob Agents Chemother. 2021; 65(11):e0067121.
PMID: 34398671
PMC: 8522753.
DOI: 10.1128/AAC.00671-21.
Laboratory-based surveillance of Shigella spp. from human clinical cases in Colombia, 1997-2018.
Rodriguez E, Bautista A, Montano L, Ovalle M, Correa F
Biomedica. 2021; 41(1):65-78.
PMID: 33761190
PMC: 8055590.
DOI: 10.7705/biomedica.5113.
The Type III Secretion System: An Overview from Top to Bottom.
Muthuramalingam M, Whittier S, Picking W, Picking W
Microorganisms. 2021; 9(2).
PMID: 33671545
PMC: 7926512.
DOI: 10.3390/microorganisms9020451.
Virulence-Related Gene Distribution Among Isolates in Anhui, China: The Association with Antimicrobial Resistance.
Liu Y, Shen W, Sun Y, Lv N, Sun K, Hu L
Infect Drug Resist. 2020; 13:3637-3647.
PMID: 33116683
PMC: 7585282.
DOI: 10.2147/IDR.S274862.
Shigella sonnei: virulence and antibiotic resistance.
Shad A, Shad W
Arch Microbiol. 2020; 203(1):45-58.
PMID: 32929595
PMC: 7489455.
DOI: 10.1007/s00203-020-02034-3.
Relative transmissibility of shigellosis among male and female individuals: a modeling study in Hubei Province, China.
Zhao Z, Chen Q, Zhao B, Hannah M, Wang N, Wang Y
Infect Dis Poverty. 2020; 9(1):39.
PMID: 32299485
PMC: 7162736.
DOI: 10.1186/s40249-020-00654-x.
Booster Vaccination With GVGH 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial.
Launay O, Ndiaye A, Conti V, Loulergue P, Scire A, Landre A
Front Immunol. 2019; 10:335.
PMID: 30906291
PMC: 6418009.
DOI: 10.3389/fimmu.2019.00335.
Characterization and Genomic Analysis of SFPH2, a Novel Infecting .
Yang C, Wang H, Ma H, Bao R, Liu H, Yang L
Front Microbiol. 2019; 9:3027.
PMID: 30619123
PMC: 6302001.
DOI: 10.3389/fmicb.2018.03027.
Two novel mutations in among isolated from Jiangsu Province of China, 2016.
Xue C, Cai J, Kang H, Chen Y, Wang K, Qian H
Ann Transl Med. 2018; 6(15):306.
PMID: 30211194
PMC: 6123205.
DOI: 10.21037/atm.2018.07.11.
Characterization of a serologically atypical Shigella flexneri Z isolated from diarrheal patients in Bangladesh and a proposed serological scheme for Shigella flexneri.
Shahnaij M, Latif H, Azmi I, Amin M, Luna S, Islam M
PLoS One. 2018; 13(8):e0202704.
PMID: 30142163
PMC: 6108489.
DOI: 10.1371/journal.pone.0202704.
Increasing clinical resistance rate of to cefotaxime in Jiangsu Province, China, between 2012 and 2015.
Qian H, Liu G, Chen Y, Ma P, Kong X, Zhou L
Ann Transl Med. 2018; 6(11):207.
PMID: 30023370
PMC: 6035990.
DOI: 10.21037/atm.2018.05.43.
Serotype Distribution and Antimicrobial Resistance of Species in Bangui, Central African Republic, from 2002 to 2013.
Breurec S, Rafai C, Onambele M, Frank T, Farra A, Legrand A
Am J Trop Med Hyg. 2018; 99(2):283-286.
PMID: 29943713
PMC: 6090317.
DOI: 10.4269/ajtmh.17-0917.
Dominant serotype distribution and antimicrobial resistance profile of Shigella spp. in Xinjiang, China.
Liu H, Zhu B, Qiu S, Xia Y, Liang B, Yang C
PLoS One. 2018; 13(4):e0195259.
PMID: 29614121
PMC: 5882154.
DOI: 10.1371/journal.pone.0195259.
Out of Asia: the independent rise and global spread of fluoroquinolone-resistant Shigella.
Chung The H, Baker S
Microb Genom. 2018; 4(4).
PMID: 29595412
PMC: 5989582.
DOI: 10.1099/mgen.0.000171.
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.
Obiero C, Ndiaye A, Scire A, Kaunyangi B, Marchetti E, Gone A
Front Immunol. 2018; 8:1884.
PMID: 29375556
PMC: 5763125.
DOI: 10.3389/fimmu.2017.01884.